英文名称 | Enfuvirtide |
中文名称 | 恩夫韦肽抗体 |
别 名 | en-FYOO-veer-tide; Fuzeon; T-20; 159519-65-0; Enfuvirtide, Acetate; |
抗体来源 | Rabbit |
克隆类型 | Polyclonal |
产品应用 | ELISA=1:5000-10000 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
分 子 量 | 4.49kDa |
性 状 | Liquid or Solid |
浓 度 | 1mg/1ml |
免 疫 原 | KLH conjugated synthetic peptide of Enfuvirtide: |
亚 型 | IgG |
纯化方法 | affinity purified by Protein A |
储 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
保存条件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
PubMed | PubMed |
产品介绍 | Enfuvirtide (INN) is an HIV fusion inhibitor, the first of a novel class of antiretroviral drugs used in combination therapy for the treatment of HIV-1 infection. It is marketed under the trade name Fuzeon (Roche). SWISS: CAS: 159519-65-0 Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |